Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease.

Marquis-Gravel G, Stebbins A, Wruck LM, Roe MT, Effron MB, Hammill BG, Whittle J, VanWormer JJ, Robertson HR, Alikhaani JD, Kripalani S, Farrehi PM, Girotra S, Benziger CP, Polonsky TS, Merritt JG, Gupta K, McCormick TE 3rd, Knowlton KU, Jain SK, Kochar A, Rothman RL, Harrington RA, Hernandez AF, Jones WS

Open source

DOI: 10.1161/jaha.122.026921
Published: 2024 Feb 20
Container: Journal of the American Heart Association
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1161/jaha.122.026921,
  title = {Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease.},
  author = {Marquis-Gravel G and Stebbins A and Wruck LM and Roe MT and Effron MB and Hammill BG and Whittle J and VanWormer JJ and Robertson HR and Alikhaani JD and Kripalani S and Farrehi PM and Girotra S and Benziger CP and Polonsky TS and Merritt JG and Gupta K and McCormick TE 3rd and Knowlton KU and Jain SK and Kochar A and Rothman RL and Harrington RA and Hernandez AF and Jones WS},
  year = {2024},
  journal = {Journal of the American Heart Association},
  doi = {10.1161/jaha.122.026921},
  url = {https://doi.org/10.1161/jaha.122.026921}
}

RIS

TY  - JOUR
TI  - Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease.
AU  - Marquis-Gravel G
AU  - Stebbins A
AU  - Wruck LM
AU  - Roe MT
AU  - Effron MB
AU  - Hammill BG
AU  - Whittle J
AU  - VanWormer JJ
AU  - Robertson HR
AU  - Alikhaani JD
AU  - Kripalani S
AU  - Farrehi PM
AU  - Girotra S
AU  - Benziger CP
AU  - Polonsky TS
AU  - Merritt JG
AU  - Gupta K
AU  - McCormick TE 3rd
AU  - Knowlton KU
AU  - Jain SK
AU  - Kochar A
AU  - Rothman RL
AU  - Harrington RA
AU  - Hernandez AF
AU  - Jones WS
PY  - 2024
JO  - Journal of the American Heart Association
DO  - 10.1161/jaha.122.026921
UR  - https://doi.org/10.1161/jaha.122.026921
ER  -

APA

G, M., A, S., LM, W., MT, R., MB, E., BG, H., J, W., JJ, V., HR, R., JD, A., S, K., PM, F., S, G., CP, B., TS, P., JG, M., K, G., 3rd, M. T., KU, K., SK, J., A, K., RL, R., RA, H., AF, H., & WS, J. (2024). Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease.. Journal of the American Heart Association. https://doi.org/10.1161/jaha.122.026921

Source records

pubmed · retrieved 2026-09-26T20:47:33.741Z